Cargando…
Intolerable side effects during propranolol therapy for infantile hemangioma: frequency, risk factors and management
Currently, propranolol is the most preferred systemic therapy for problematic infantile hemangiomas (IHs). However, the side effects such as bronchial hyperreactivity may be intolerable. The aim of this study was to evaluate the frequency, risk factors and management of intolerable side effects (ISE...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5844887/ https://www.ncbi.nlm.nih.gov/pubmed/29523832 http://dx.doi.org/10.1038/s41598-018-22787-8 |